Good morning—Thursday, December 18, 2025
You’re running on coffee and FOMO, so here’s what moved markets in the last 24 hours:
Market Pulse
Chip stocks ripped higher after Micron’s blowout Q1 results sparked a sector-wide surge while energy jitters from Venezuela’s tanker blockade keep traders cautious. The S&P drifted into mixed territory as Oracle’s execution troubles weighed on broader tech sentiment.
Key Movers
Micron lit the fuse, followed by gains in Sandisk and Western Digital, as reported in “Sandisk up 2.9%, Western Digital up 1.4% following Micron Q1 earnings beat” (Thefly.com). In biopharma, GSK’s Exdensur and MediBeacon’s TGFR system both scored FDA clearance (“MediBeacon® Next Generation TGFR™ System Receives FDA Approval”, GlobeNewswire). Beyond Air also made headlines with new LungFit PH® distribution agreements in Germany and Brazil.
Macro & Politics
Traders remain stuck between Fed rate-cut speculation and fresh White House blockade measures on Venezuelan oil. Antitrust chatter in Congress lurks behind the scenes and could snap a rally into reverse.
What’s Next
Keep an eye on Fed minutes for clues on interest rates and watch for chip analyst upgrades that could amplify today’s momentum.
Enhanced Market Commentary
Everyone’s fixated on “Micron up 6% at $239.27 after Q1 earnings beat, above-consensus guide” (Thefly.com) and cheering the flash-storage surge, but nobody’s mentioning that an oil blockade off Venezuela can still jar tech momentum (“Stock market today: Dow, S&P 500, Nasdaq trade mixed as Wall Street weighs odds of rate cuts, Oracle sinks”, Yahoo Entertainment). That disconnect could leave over-leveraged longs exposed if the energy shock spreads.
Combine the veteran playbook unveiled in “A short-seller who bet against now-bankrupt iRobot for a decade unpacks how he identifies his bearish targets” (Business Insider) with the sector-wide chip rally and you have a textbook recipe for sudden reversals. If burnt-cash names in tech or biotech get tagged by fresh negative catalysts, expect an abrupt flip in sentiment.
Here’s the tactic: flag the Fed minutes and the “Costco downgraded, Dollar General upgraded: Wall Street’s top analyst calls” (Yahoo Entertainment) list, then front-run any analyst revisions in the memory-chip group. And don’t overlook biotech catalysts—“GSK announces FDA approval of Exdensur for severe asthma treatment” (Thefly.com) shows how regulatory nods can ignite a sprint.
📈 Breaking Financial News
Sandisk up 2.9%, Western Digital up 1.4% following Micron Q1 earnings beat
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corpor…
Micron up 6% at $239.27 after Q1 earnings beat, above-consensus guide
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corpor…
GSK announces FDA approval of Exdensur for severe asthma treatment
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corpor…
MediBeacon® Next Generation TGFR™ System Receives FDA Approval
NEW YORK, Dec. 16, 2025 (GLOBE NEWSWIRE) — INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that MediBeacon Inc. (“MediBeacon”), a medical technology company specializing in the advancement of fluorescent tracer agents and their tran…
Sequana Medical Announces Granting of Key Additional U.S. Patent for DSR
Ghent, Belgium, Dec. 18, 2025 (GLOBE NEWSWIRE) — Sequana Medical NV (Euronext Brussels: SEQUA, the “Company” or “Sequana Medical”), a pioneer in the treatment of drug-resistant fluid overload in liver disease, heart failure and cancer, today announces the gr…
Get out of “The World's Most Crowded Trade” Now
Megacap tech stocks – like Nvidia – could be headed for a shakeout. 78% of Wall Street fund managers expect a seismic shift this September. Watch Futurist Eric Fry's “Sell This, Buy That” broadcast for 7 alternative plays to protect yourself from big tech's potential downturn. Get all the analysis, names and tickers FREE right here.
🔍 Market Analysis & Insights
Best XRP Buy Zone? Analyst Breaks Down The Key Levels
Will Taylor, founder of CryptoinsightUK, frames XRP’s “best buy area” as a risk-to-reward question, not a certainty call. In his latest YouTube video from Dec. 17, he argues that XRP is trading back in the lower portion of a well-defined range, which is typic…
United States Multiple Myeloma Market Report: Growth Drivers and Challenges 2025-2033
Dublin, Dec. 17, 2025 (GLOBE NEWSWIRE) — The “United States Multiple Myeloma Market Report by Drugs Types, Disease Types, End User, States and Company Analysis, 2025-2033” has been added to ResearchAndMarkets.com's offering.The United States Multiple Myeloma…
Transparency Notification from Shareholders
Ghent, Belgium, Dec. 17, 2025 (GLOBE NEWSWIRE) — Transparency Notification from ShareholdersPRESS RELEASEREGULATED INFORMATION 17 December 2025, 6:00…
A short-seller who bet against now-bankrupt iRobot for a decade unpacks how he identifies his bearish targets
Spruce Point Capital first bet against shares of the Roomba maker in 2015. Its founder shares how he approaches short-selling.
Transcatheter Heart Valve Replacement Market Size to Reach USD 19.98 Billion by 2033, Growing at a CAGR of 15.32% – SNS Insider
Rising prevalence of valvular heart diseases, expanding elderly population, and growing preference for minimally invasive cardiac procedures are driving the transcatheter heart valve replacement market’s growth. Rising prevalence of valvular heart diseases, e…
Alert: The DeFi Token Set to Explode as Markets Recover
This isn’t speculation – this platform’s role is so essential to crypto’s financial system that its current price defies all logic. Just Released: The DeFi token set for massive gains as markets heat up – only $3!
💰 Investment Opportunities
Pediatric studies and labeling additions required by the U.S. FDA for novel drugs approved from 2011 to 2023: A retrospective cohort study
In a retrospective analysis of US FDA records of novel, approved drugs with pediatric study requirements, Rylee McGonigle and colleagues report that less than 60% of requirements were met a decade post-approval, and labeling changes were substantially delayed…
Beyond Air® Signs New International LungFit PH® Distribution Agreements, Most Notably in Germany and Brazil
Distribution network coverage expanded to a total of 39 countries Distribution network coverage expanded to a total of 39 countries
Stock market today: Dow, S&P 500, Nasdaq trade mixed as Wall Street weighs odds of rate cuts, Oracle sinks
Stocks are leaning higher as oil gains after Trump placed a blockade on tankers off Venezuela.
Costco downgraded, Dollar General upgraded: Wall Street’s top analyst calls
The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, …
Elon Musk's Final Project REVEALED
It's a secret project … bigger than Tesla … bigger than SpaceX … and bigger than Twitter. Inside this warehouse in Memphis Tennessee… Lies a new technology that is 100,000 times more powerful than Nvidia's most advanced AI chip. Get the full details on Elon’s secret new AI project now.